Article info
PDFOriginal article
Assessment of bevacizumab quality and stability in repackaged syringes for clinical use
- Correspondence to Dr A Santoveña, Departamento de Ingeniería Química y Tecnología Farmacéutica, Facultad de Farmacia, Universidad de La Laguna, La Laguna 38200, Tenerife, Spain; ansanto{at}ull.es
Citation
Assessment of bevacizumab quality and stability in repackaged syringes for clinical use
Publication history
- Received December 10, 2015
- Revised February 3, 2016
- Accepted February 25, 2016
- First published March 21, 2016.
Online issue publication
May 01, 2020
Article Versions
- Previous version (27 March 2017).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/